Chasing leaders, Juno rides CAR-T momentum into ASH – BioPharma Dive
|
Chasing leaders, Juno rides CAR–T momentum into ASH
BioPharma Dive For a field that not too long ago was considered science fiction, CAR–T cell therapy has transitioned from the clinic to the market in remarkable speed. This year's annual meeting of the American Society of Hematology (ASH), set to kick off Saturday … |
